Zhiqi Zeng, Jingyi Liang, Zhijie Lin, Wenda Guan, Wei He, Qianying Li, Lixi Liang, Weiqi Pan, Zige Liu, Guibin Lu, Xiaoyan Deng, Eric HY Lau, Chitin Hon, Zifeng Yang. The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality — Hong Kong SAR, China, 2022J. China CDC Weekly, 2024, 6(21): 469-477. DOI: 10.46234/ccdcw2024.092
|
Citation:
|
Zhiqi Zeng, Jingyi Liang, Zhijie Lin, Wenda Guan, Wei He, Qianying Li, Lixi Liang, Weiqi Pan, Zige Liu, Guibin Lu, Xiaoyan Deng, Eric HY Lau, Chitin Hon, Zifeng Yang. The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality — Hong Kong SAR, China, 2022J. China CDC Weekly, 2024, 6(21): 469-477. DOI: 10.46234/ccdcw2024.092
|
Zhiqi Zeng, Jingyi Liang, Zhijie Lin, Wenda Guan, Wei He, Qianying Li, Lixi Liang, Weiqi Pan, Zige Liu, Guibin Lu, Xiaoyan Deng, Eric HY Lau, Chitin Hon, Zifeng Yang. The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality — Hong Kong SAR, China, 2022J. China CDC Weekly, 2024, 6(21): 469-477. DOI: 10.46234/ccdcw2024.092
|
Citation:
|
Zhiqi Zeng, Jingyi Liang, Zhijie Lin, Wenda Guan, Wei He, Qianying Li, Lixi Liang, Weiqi Pan, Zige Liu, Guibin Lu, Xiaoyan Deng, Eric HY Lau, Chitin Hon, Zifeng Yang. The Impact of Medical Resources and Oral Antiviral Drugs on SARS-CoV-2 Mortality — Hong Kong SAR, China, 2022J. China CDC Weekly, 2024, 6(21): 469-477. DOI: 10.46234/ccdcw2024.092
|
DownLoad: